The evidence for the use of beta-blockers in heart failure is substantial.
Latest recommendations and guidelines suggest that retest heart failure pat
ients should be on a drug regimen of an angiotensin-converting enzyme inhib
itor diuretic and a beta-blocker. However, despite the evidence front trial
s, the majority of patient are not yet treated appropriately, with only 5%
receiving a beta-blocker.